Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
Condition: Anemia; Hemodialysis Dependent Chronic Kidney Disease Intervention: Drug: MT-6548 Sponsor: Mitsubishi Tanabe Pharma Corporation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anemia | Chronic Kidney Disease | Dialysis | Hemodialysis | Japan Health | Study | Urology & Nephrology